Scientists find inflammation immune cell switch

Scientists have found a protein that acts as a master switch to determine whether certain white blood cells will boost or dampen inflammation, a finding that may help the search for new drugs for rheumatoid arthritis.

Roche to slash 4,800 jobs amid healthcare cost pressures

Swiss pharma giant Roche said it plans to cut 4,800 jobs worldwide over the next two years due to mounting cost pressures in healthcare -particularly in the US and Europe - and increasing hurdles for the approval and pricing of new medicines.

Alcohol offers protection, relief from rheumatoid arthritis

Drinking alcohol regularly may not be too bad for the health, at least for rheumatoid arthritis sufferers or those at high risk of acquiring the painful condition. A study by British researchers showed that non-drinkers were more prone to developing the debilitating condition than those who drank alcohol more than 10 days per month.

Latest rheumatoid arthritis drug for Australians

Rheumatoid arthritis (RA) affects about one per cent of Australian population. Patients with the condition usually have to live with progressive joint destruction, disability, deformity and a reduced life span, even with treatments.

Merck profit beats Wall Street view

Merck & Co reported higher-than-expected second-quarter earnings on Friday, helped by strong sales of its treatments for diabetes, arthritis and HIV.

New guideline on osteoporosis for Australian GPs

To address the significant health consequence of osteoporosis, under diagnosis and under treatment of the disease, the Royal Australian College of General Practitioners (RACGP) has launched a new osteoporosis guideline to provide clear, evidence-based recommendations to assist GPs in the management of osteoporosis sufferers.

Roche, Biogen suspends arthritis drug after deaths

Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future.


IBTimes Logo

J&J expands recall of Tylenol arthritis caplets

A voluntary recall of Tylenol Arthritis Pain Caplets is being expanded because of consumer reports of an unusual moldy odor with the 100-count bottles, the U.S. Food and Drug Administration said late on Monday.
IBTimes Logo

Bristol-Myers buys rights to RA drug $85 million

Bristol-Myers Squibb Co said on Tuesday it agreed to pay $85 million for the rights to an experimental rheumatoid arthritis drug being developed by privately held biotechnolgy company Alder Biopharmaceuticals Inc.